Collectively, sirt1 AS was critical for ASV-mediated inhibition of IPF progression and targeting of sirt1 AS by ASV could be a potential therapeutic approach for IPF. This evidence concerns the gene SIRT1 and idiopathic pulmonary fibrosis.